Assessing the Performance of Confirmatory Cognitive Tests in Screening Subjects for Early Alzheimer's Disease Clinical Trials

Abstract

Background: In early Alzheimer's Disease clinical trials, confirmatory cognitive tests such as the FCSRT, RBANS and Wechsler Memory Scale (WMS)‐Logical Memory II are often used at Screening to assure that only subjects with objectifiable cognitive decline are included in the clinical trial.

The paper